The changing landscape of myeloma therapy

被引：27

作者：

Cavo, M ^{[1
]}

Baccarani, M ^{[1
]}

机构：

[1] Univ Bologna, Inst Hematol & Med Oncol Seragnoli, Bologna, Italy

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2006年 / 354卷 / 10期

关键词：

D O I：

10.1056/NEJMe058322

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1076 / 1078

页数：3

共 14 条

[1]

Attal M, 2005, BLOOD, V106, p335A

[2]

Attal M, 2004, NEW ENGL J MED, V350, P1467

[3] Treatment of multiple myeloma [J].

Barlogie, B ;

Shaughnessy, J ;

Tricot, G ;

Jacobson, J ;

Zangari, M ;

Anaissie, E ;

Walker, R ;

Crowley, J .

BLOOD, 2004, 103 (01) :20-32

[4] Thalidomide and hematopoietic-cell transplantation for multiple myeloma [J].

Barlogie, B ;

Tricot, G ;

Anaissie, E ;

Shaughnessy, J ;

Rasmussen, E ;

van Rhee, F ;

Fassas, A ;

Zangari, M ;

Hollmig, K ;

Pineda-Roman, M ;

Lee, C ;

Talamo, G ;

Thertulien, R ;

Kiwan, E ;

Krishna, S ;

Fox, M ;

Crowley, J .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (10) :1021-1030

[5] Superiority of double over single autologous stem cell transplantation as first-line therapy for multiple myeloma. [J].

Cavo, M ;

Cellini, C ;

Zamagni, E ;

Tosi, P ;

Cangini, D ;

Tacchetti, P ;

de Vivo, A ;

Perrone, G ;

Lemoli, RM ;

Tura, S ;

Baccarani, M .

BLOOD, 2004, 104 (11) :155A-156A

[6] Superiority of thalidomide and dexamethasone over vincristine-doxorubicin-dexamethasone (VAD) as primary therapy in preparation for autologous transplantation for multiple myeloma [J].

Cavo, M ;

Zamagni, E ;

Tosi, P ;

Tacchetti, P ;

Cellini, C ;

Cangini, D ;

de Vivo, A ;

Testoni, N ;

Nicci, C ;

Terragna, C ;

Grafone, T ;

Perrone, G ;

Ceccolini, M ;

Tura, S ;

Baccarani, M .

BLOOD, 2005, 106 (01) :35-39

[7]

Dimopoulos MA, 2005, BLOOD, V106, p6A

[8] Drug therapy: Multiple myeloma [J].

Kyle, RA ;

Rajkumar, SV .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (18) :1860-1873

[9]

Kyle RA, 2005, NEW ENGL J MED, V352, P1163

[10]

Palumbo A, 2005, BLOOD, V106, p230A

← 1 2 →